June 1, 2016 / 7:32 PM / in a year

BRIEF-Arch Biopartners says European Commission designated AB569 as orphan medicinal product in EU

June 1 (Reuters) - Arch Biopartners Inc :

* European Commission designated AB569 as orphan medicinal product in European Union for treatment of patients with cystic fibrosis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below